| CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex K Masternak, A Muhlethaler-Mottet, J Villard, M Zufferey, V Steimle, ... Genes & development 14 (9), 1156-1166, 2000 | 400 | 2000 |
| The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors C De Rham, S Ferrari-Lacraz, S Jendly, G Schneiter, JM Dayer, J Villard Arthritis research & therapy 9, 1-15, 2007 | 215 | 2007 |
| De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients I Katerinis, K Hadaya, R Duquesnoy, S Ferrari-Lacraz, S Meier, ... American Journal of Transplantation 11 (8), 1727-1733, 2011 | 166 | 2011 |
| GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. J Villard, F Dayer-Pastore, J Hamacher, JD Aubert, S Schlegel-Haueter, ... American journal of respiratory and critical care medicine 152 (5), 1549-1554, 1995 | 145 | 1995 |
| First experience of SARS‐CoV‐2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study J Tschopp, AG L'Huillier, M Mombelli, NJ Mueller, N Khanna, C Garzoni, ... American Journal of Transplantation 20 (10), 2876-2882, 2020 | 126 | 2020 |
| Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab D Hristea, K Hadaya, N Marangon, L Buhler, J Villard, P Morel, PY Martin Transplant International 20 (1), 102-105, 2007 | 126 | 2007 |
| Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation K Hadaya, S Ferrari‐Lacraz, D Fumeaux, F Boehlen, C Toso, S Moll, ... American Journal of Transplantation 11 (11), 2523-2527, 2011 | 115 | 2011 |
| Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation S Riethmüller, S Ferrari-Lacraz, MK Müller, DA Raptis, K Hadaya, B Rüsi, ... Transplantation 90 (2), 160-167, 2010 | 115 | 2010 |
| Transcription regulation and human diseases J Villard Swiss medical weekly 134 (3940), 571-571, 2004 | 113 | 2004 |
| Potential and limitation of HLA‐based banking of human pluripotent stem cells for cell therapy C de Rham, J Villard Journal of immunology research 2014 (1), 518135, 2014 | 106 | 2014 |
| Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation K Hadaya, C De Rham, C Bandelier, S Ferrari-Lacraz, S Jendly, T Berney, ... American Journal of Transplantation 8 (12), 2674-2683, 2008 | 105 | 2008 |
| Lessons from bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. JM Waldburger, K Masternak, A Muhlethaler-Mottet, J Villard, M Peretti, ... Immunological reviews 178 (1), 2000 | 104 | 2000 |
| Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94 … V Bigouret, T Hoffmann, L Arlettaz, J Villard, M Colonna, A Ticheli, ... Blood, The Journal of the American Society of Hematology 101 (8), 3198-3204, 2003 | 103 | 2003 |
| Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells O Preynat‐Seauve, C de Rham, D Tirefort, S Ferrari‐Lacraz, KH Krause, ... Journal of cellular and molecular medicine 13 (9b), 3556-3569, 2009 | 90 | 2009 |
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study D Neofytos, O Chatzis, D Nasioudis, E Boely Janke, T Doco Lecompte, ... Transplant infectious disease 20 (4), e12898, 2018 | 89 | 2018 |
| Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity A Pradier, J Passweg, J Villard, V Kindler Cell transplantation 20 (5), 681-691, 2011 | 87 | 2011 |
| A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y J Villard, M Peretti, K Masternak, E Barras, G Caretti, R Mantovani, ... Molecular and cellular biology 20 (10), 3364-3376, 2000 | 86 | 2000 |
| Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR αβ lymphocytes L Arlettaz, J Villard, C De Rham, S Degermann, B Chapuis, B Huard, ... European journal of immunology 34 (12), 3456-3464, 2004 | 85 | 2004 |
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark T Berney, S Ferrari-Lacraz, L Bühler, J Oberholzer, N Marangon, ... American journal of transplantation 9 (2), 419-423, 2009 | 81 | 2009 |
| Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency J Villard, B Lisowska-Grospierre, P van den Elsen, A Fischer, W Reith, ... New England Journal of Medicine 337 (11), 748-753, 1997 | 81 | 1997 |
